Prognostic value of blood flow measurements using arterial spin labeling in gliomas

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Furtner, Julia ^a,b   Bender, Benjamin ^b   Braun, Christian ^b   Schittenhelm, Jens ^b   Skardelly, Marco ^b   Ernemann, Ulrike ^b   Bisdas, Sotirios ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERIAL SPIN LABELING; ARTICLE; ASTROCYTOMA; BLOOD FLOWMETRY; CANCER GRADING; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; MALE; PERFUSION WEIGHTED IMAGING; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPIN LABELING; TUMOR BLOOD FLOW; BLOOD; BLOOD FLOW; FOLLOW UP; HEMODYNAMICS; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS;

SPIN LABELING;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; REGIONAL BLOOD FLOW; ROC CURVE; SPIN LABELS;

EID: 84902595125     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099616     Document Type: Article

References (29)

1. Mangla R, Ginat DT, Kamalian S, Milano MT, Korones DN, et al. (2013) Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes. Journal of Neurooncology DOI 10.1007/s11060-013-1298-9.
2. Weller M, Felsberg J, Hartmann C, Berger H, Steinbach JP, et al. (2009) Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. Journal of Clinical Oncology 34: 5743-5750.
3. Walker C, du Plessis DG, Joyce KA, Machell Y, Thomson-Hehir J, et al. (2003) Phenotype versus genotype in gliomas displaying inter- or intratumoral histological heterogeneity. Clinical Cancer Research 9: 4841-4851. (Pubitemid 37323288)
4. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK. (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 7: 1381-1393. (Pubitemid 27143246)
5. Prayson RA, Agamanolis DP, Cohen ML, Estes ML, Kleinschmidt-DeMasters BK, et al. (2000) Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. Journal of Neurological Science 1: 33-39. (Pubitemid 30227481)
6. Jackson RJ, Fuller GN, Abi-Said D, Lang FF, Gokaslan ZL, et al. (2001) Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-Oncology 3: 193-200. (Pubitemid 33674111)
7. Louis DN, Ohgaki H, Wiestler D, Cavenee WK, Burger PC, et al. (2007) WHO Classification of Tumours of the Central Nervous System. Lyon: IARC Press.
8. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. (2010) Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 3: 647-649.
9. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, et al. (1998) A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magnetic Resonance in Medicine 3: 383-396. (Pubitemid 28391899)
10. Järnum H, Steffensen EG, Knutsson L, Fründ ET, Simonsen CW, et al. (2010) Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology 4: 307-317.
11. Warmuth C, Gunther M, Zimmer C. (2003) Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 2: 523-532. (Pubitemid 36910097)
12. Weber MA, Günther M, Lichy MP, Delorme S, Bongers A, et al. (2003) Comparison of arterial spin-labeling techniques and dynamic susceptibility- weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue. Investigative Radiology 11: 712-718. (Pubitemid 38004496)
13. Hirai T, Kitajima M, Nakamura H, Okuda T, Sasao A, et al. (2011) Quantitative Blood Flow Measurements in Gliomas Using Arterial Spin- Labeling at 3T: Intermodality Agreement and Inter- and intraobserver reproducibility study. American Journal of Neuroradiology 11:2073-2079.
14. Seeger A, Braun C, Skardelly M, Paulsen F, Schittenhelm J, et al. (2013) Perfusion Techniques and MR Spectroscopy for Multiparametric Recurrent High-Grade Gliomas. Academic Radiology 12: 1557-1565.
15. Chen Y, Wang DJJ, Detre JA (2011) Test-retest reliability of arterial spin labeling with common labeling strategies. Journal of Magnetic Resonance Imaging 4: 940-949.
16. Golay X, Petersen E (2006) Arterial spin labeling: benefits and pitfalls of high magnetic field. Neuroimaging Clinics of North America 16: 259-268. (Pubitemid 43775486)
17. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, et al. (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. American Journal of Neuroradiology 2: 214-221. (Pubitemid 38235298)
18. Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, et al. (2009) Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease? American Journal of Neuroradiology 4: 681-688.
19. Senft C, Bink A, Franz K, Vatter H, Gasser T, et al. (2011) Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncology 12:997-1003.
20. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, et al. (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 5:392-401.
21. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, et al. (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. Journal of Clinical Oncology 11: 1963-1972.
22. Wong EC, Buxton RB, Frank LR (1997) Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling. NMR in Biomedicine 10: 237-249. (Pubitemid 27519924)
23. Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, et al. (2008) Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. American Journal of Neuroradiology 29:1228-1234.
24. Wong EC, Buxton RB, Frank LR (1998) Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II). Magnetic Resonance in Medicine 39:702-708. (Pubitemid 28189141)
25. Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, et al. (2008) Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging," Radiology 247: 490-498.
26. Law M, Oh S, Babb JS, Wang E, Inglese M, et al. (2006) Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging - prediction of patient clinical response. Radiology 238:658-667. (Pubitemid 43134379)
27. Hirai T, Murakami R, Nakamura H, Kitajima M, Fukuoka H, et al. (2008) Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study. American Journal of Neuroradiology 29: 1505-1510.
28. Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken R, et al. (2006) Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT. International Journal of Radiation Oncology, Biology, Physics 64: 876-885. (Pubitemid 43183588)
29. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, et al. (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro-Oncology 15:1-56.